Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Non-Rx Zocor Will Be Available In UK Without Cholesterol Screen Requirement

This article was originally published in The Tan Sheet

Executive Summary

Customers who present at UK pharmacies to purchase McNeil Europe's Zocor Heart-Pro (simvastatin 10 mg) without a prescription will need to disclose risk factors such as age and family history of heart disease, but not necessarily their cholesterol level, under a marketing plan cleared by the UK health agency

You may also be interested in...



Primary Prevention Of Heart Risk Factors Trumps Secondary Prevention – BMJ

Primary prevention strategies to reduce the CHD risk factors of smoking, high cholesterol and hypertension "achieved a four-fold larger reduction in deaths" compared to secondary prevention over a twenty-year period in the UK, according to a British Medical Journal study

Primary Prevention Of Heart Risk Factors Trumps Secondary Prevention – BMJ

Primary prevention strategies to reduce the CHD risk factors of smoking, high cholesterol and hypertension "achieved a four-fold larger reduction in deaths" compared to secondary prevention over a twenty-year period in the UK, according to a British Medical Journal study

Primary Prevention Of Heart Risk Factors Trumps Secondary Prevention – BMJ

Primary prevention strategies to reduce the CHD risk factors of smoking, high cholesterol and hypertension "achieved a four-fold larger reduction in deaths" compared to secondary prevention over a twenty-year period in the UK, according to a British Medical Journal study

Related Content

Topics

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel